DMAC icon

DiaMedica Therapeutics
DMAC

Overview Fund Activity

34 hedge funds and large institutions have $10M invested in DiaMedica Therapeutics in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 6 closing their positions.

Holders
34
Holders Change
-5
Holders Change %
-12.82%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
9
Reduced
13
Closed
6
Calls
$157K
Puts
$87K
Net Calls
+$70K
Net Calls Change
+$234K

Top Buyers

1
CLG
1
Cooperman Leon G
$2.03M
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$145K
3
IC
3
Ikarian Capital
Texas
$553K
4
Morgan Stanley
4
Morgan Stanley
New York
$84K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$437K

Top Sellers

1
MHP
1
Manatuck Hill Partners
Connecticut
$0
2
AFM
2
Anson Funds Management
Texas
$0
3
Two Sigma Investments
3
Two Sigma Investments
New York
$125K
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$124K
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$2K -$7.72K -3,668 -79%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$2K – – –
Citigroup
28
Citigroup
New York
$1K +$1K +273 New
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Quebec, Canada
$575 – – –
MHP
30
Manatuck Hill Partners
Connecticut
– -$540K -144,800 Closed
AFM
31
Anson Funds Management
Texas
– -$485K -130,070 Closed
Millennium Management
32
Millennium Management
New York
– -$83K -22,249 Closed
JF
33
Jump Financial
Illinois
– -$81K -21,800 Closed
Marshall Wace
34
Marshall Wace
United Kingdom
– -$38K -10,031 Closed
Simplex Trading
35
Simplex Trading
Illinois
– -$23K -6,350 Closed
1
2